Author Index

Search or browse for an author across our entire electronic archive

Search results for: O
Results 71 - 80 of 688 shown below

  • O'Donnell, J

    M S Cunningham, B White, D Hollywood and J O'Donnell

    Primary thromboprophylaxis for cancer patients with central venous catheters – a reappraisal of the evidence

    advance online publication, 2006-01-10 00:00:00.000;

    doi:10.1038/sj.bjc.6602917

  • O'Donnell, P H

    P H O'Donnell and M J Ratain

    Evaluating the activity of temsirolimus in neuroendocrine cancer

    advance online publication, 2006-12-12 00:00:00.000;

    doi:10.1038/sj.bjc.6603513

  • O'Donoghue, D

    J Sheridan, L-M Wang, M Tosetto, K Sheahan, J Hyland, D Fennelly, D O'Donoghue, H Mulcahy and J O'Sullivan

    Nuclear oxidative damage correlates with poor survival in colorectal cancer

    advance online publication, 2008-12-09 00:00:00.000;

    doi:10.1038/sj.bjc.6604821

  • O'Donovan, N

    B Ryan, N O'Donovan, B Browne, C O'Shea, J Crown, A D K Hill, E McDermott, N O'Higgins and M J Duffy

    Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer

    advance online publication, 2004-12-21 00:00:00.000;

    doi:10.1038/sj.bjc.6602314

  • O'Donovan, P

    C A Harwood, N R Attard, P O'Donovan, P Chambers, C M Perrett, C M Proby, J M McGregor and P Karran

    PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients

    doi:10.1038/sj.bjc.6604665

  • O'Donovan, T R

    G O'Sullivan-Coyne, G C O'Sullivan, T R O'Donovan, K Piwocka and S L McKenna

    Curcumin induces apoptosis-independent death in oesophageal cancer cells

    advance online publication, 2009-10-06 00:00:00.000;

    doi:10.1038/sj.bjc.6605308

  • O'Driscoll, L

    S Kennedy, M Clynes, P Doolan, J P Mehta, S Rani, J Crown and L O'Driscoll

    SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue

    advance online publication, 2008-05-13 00:00:00.000;

    doi:10.1038/sj.bjc.6604365

  • O'Dwyer, M

    E Szegezdi, S Cahill, M Meyer, M O'Dwyer and A Samali

    TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt

    advance online publication, 2006-01-24 00:00:00.000;

    doi:10.1038/sj.bjc.6602954

  • O'Dwyer, P J

    D Roberts, J Schick, S Conway, S Biade, P B Laub, J P Stevenson, T C Hamilton, P J O'Dwyer and S W Johnson

    Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells

    advance online publication, 2005-02-22 00:00:00.000;

    doi:10.1038/sj.bjc.6602447

  • M L Veronese, W Sun, B Giantonio, J Berlin, J Shults, L Davis, D G Haller and P J O'Dwyer

    A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer

    advance online publication, 2005-05-03 00:00:00.000;

    doi:10.1038/sj.bjc.6602569

  • K Yao, J A Gietema, S Shida, M Selvakumaran, X Fonrose, N B Haas, J Testa and P J O'Dwyer

    In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo

    doi:10.1038/sj.bjc.6602864

  • T Eisen, T Ahmad, K T Flaherty, M Gore, S Kaye, R Marais, I Gibbens, S Hackett, M James, L M Schuchter, K L Nathanson, C Xia, R Simantov, B Schwartz, M Poulin-Costello, P J O'Dwyer and M J Ratain

    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

    advance online publication, 2006-08-01 00:00:00.000;

    doi:10.1038/sj.bjc.6603291

  • S Biade, M Marinucci, J Schick, D Roberts, G Workman, E H Sage, P J O'Dwyer, V A LiVolsi and S W Johnson

    Gene expression profiling of human ovarian tumours

    advance online publication, 2006-09-12 00:00:00.000;

    doi:10.1038/sj.bjc.6603346

  • O'Dwyer, S T

    A G Renehan, W S Atkin, S T O'Dwyer and S M Shalet

    The effect of cigarette smoking use and cessation on serum insulin-like growth factors

    advance online publication, 2004-08-31 00:00:00.000;

    doi:10.1038/sj.bjc.6602150

  • A G Renehan, M Egger, M P Saunders and S T O'Dwyer

    Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis

    advance online publication, 2005-02-01 00:00:00.000;

    doi:10.1038/sj.bjc.6602369

  • S P Bach, S E Williamson, S T O'Dwyer, C S Potten and A J M Watson

    Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut

    doi:10.1038/sj.bjc.6603224

  • R Bibi, N Pranesh, M P Saunders, M S Wilson, S T O'Dwyer, P L Stern and A G Renehan

    A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei

    advance online publication, 2006-10-10 00:00:00.000;

    doi:10.1038/sj.bjc.6603398

  • M M Seenath, D Roberts, C Cawthorne, M P Saunders, G R Armstrong, S T O'Dwyer, I J Stratford, C Dive and A G Renehan

    Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein Bid in ex vivo colorectal cancer

    advance online publication, 2008-07-22 00:00:00.000;

    doi:10.1038/sj.bjc.6604474

  • A L Farquharson, N Pranesh, G Witham, R Swindell, M B Taylor, A G Renehan, S Rout, M S Wilson, S T O'Dwyer and M P Saunders

    A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei

    advance online publication, 2008-08-05 00:00:00.000;

    doi:10.1038/sj.bjc.6604522

  • A G Renehan, J Jones, C S Potten, S M Shalet and S T O'Dwyer

    Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer

    doi:10.1054/bjoc.2000.1462